MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 20 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $8,811,000,000 | +15.9% | 6,500,000 | -13.3% | 0.17% | +20.1% |
| Q1 2014 | $7,605,000,000 | -26.9% | 7,500,000 | -25.0% | 0.14% | -24.6% |
| Q4 2013 | $10,407,000,000 | +4.1% | 10,000,000 | -9.1% | 0.19% | -8.2% |
| Q3 2013 | $10,001,000,000 | – | 11,000,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 16,490,000 | $25,947,000 | 12.49% |
| SILVERBACK ASSET MANAGEMENT LLC | 14,500,000 | $22,711,000 | 2.37% |
| TANG CAPITAL MANAGEMENT LLC | 3,500,000 | $5,259,000 | 1.94% |
| ARISTEIA CAPITAL, L.L.C. | 11,932,000 | $18,727,000 | 0.95% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,600,000 | $19,576,000 | 0.46% |
| Polar Capital LLP | 3,120,000 | $4,965,000 | 0.10% |
| Tekla Capital Management LLC | 1,485,000 | $2,336,000 | 0.08% |
| MIZUHO SECURITIES USA LLC | 194,000 | $305,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,410,000 | $2,206,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 11,010,000 | $17,375,000 | 0.04% |